Please enable JavaScript to view advertisements.
×
App Icon
The Standard e-Paper
Smart Minds Choose Us
★★★★ - on Play Store
Download App

Hormone therapy for breast cancer patients may reduce dementia risk, study shows

Phanice Okuso, 60, a retired nurse conducting a breast cancer screening at Kakamega Oasis Multi-Specialty Hospital. [Nathan Ochunge, Standard]

Hormone Modulating Therapy (HMT), widely used to treat hormone receptor-positive breast cancer, could offer more than just cancer treatment. It may lower the risk of dementia.

A recent study revealed a 7 per cent reduced risk of Alzheimer's Disease and Related Dementias (ADRD) among breast cancer patients who underwent HMT, although this benefit decreases with age and varies by race.

Premium Article

Get Full Access for Ksh299/Week.

Uncover the stories others won't tell. Subscribe now for exclusive access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
Support Independent Journalism

Stand With Bold Journalism.
Stand With The Standard.

Journalism can't be free because the truth demands investment. At The Standard, we invest time, courage and skills to bring you accurate, factual and impactful stories. Subscribe today and stand with us in the pursuit of credible journalism.

Pay via
M - PESA
VISA
Airtel Money
Secure Payment Kenya's most trusted newsroom since 1902

Follow The Standard on Google News